📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy. (2021)

First Author: Ioannou N

Attributed to: Evaluation of the CD4+ T cell tumour microenvironment of low grade B cell lymphoproliferative disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2020006073

PubMed Identifier: 33024998

Publication URI: http://europepmc.org/abstract/MED/33024998

Type: Journal Article/Review

Volume: 137

Parent Publication: Blood

Issue: 2

ISSN: 0006-4971